The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless misleading, sleazy marketing is in the mission statement. In that case, ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Regular use of NSAID pain relievers, like ibuprofen, is a known risk factor for both acute and chronic gastritis. “MOH, or rebound headaches, is when someone with a preexisting primary headache ...

Strides Pharma Science Ltd announced that its subsidiary, Strides Pharma Global Pte. Limited in Singapore, has received USFDA ...

FDA approves Journavx, a non-opioid medication for moderate to severe acute pain. Learn about its efficacy and side effects.